Start for free
Start for free
Genentech logo

Genentech

North America, California, United States, South San Francisco

Description

Computer Vision Startup

Investor Profile

Genentech has made 9 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (33%)
  • Series D (22%)
  • Series A (22%)
  • Undisclosed (11%)
  • Series Unknown (11%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Life Science
  • Genetics
  • Medical Device
  • Alternative Medicine
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Genentech frequently co-invest with?

Duke University
Duke University
North America, North Carolina, United States, Durham
Co-Investments: 2
Sprout Group
Sprout Group
North America, New York, United States, New York
Co-Investments: 2
HealthCare Ventures
HealthCare Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
Skyline Ventures
Skyline Ventures
North America, California, United States, Palo Alto
Co-Investments: 2
NV
NIF Ventures
North America, California, United States, Palo Alto
Co-Investments: 2
Alta Partners
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 2
Rho Ventures
Rho Ventures
North America, New York, United States, New York
Co-Investments: 2
BS
Bear Stearns Health Innoventures L.P
North America, New York, United States, New York
Co-Investments: 2
Yasuda Enterprise Development
Yasuda Enterprise Development
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
Vertex Management
Vertex Management
Asia, Central Region, Singapore, Singapore
Co-Investments: 2

Which angels does Genentech often collaborate with?

WM
Wendi Murdoch
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Genentech?

Yale Cancer Center

New Haven, Connecticut, United States

Yale Cancer Center provides research, diagnosis, treatment, and clinical trials.

Health CareMedical
UndisclosedMar 6, 2023
23andMe

Sunnyvale, California, United States

23andMe is a DNA testing technology company that enables its users to access their ancestry, genealogy, and inherited traits.

BiotechnologyGeneticsLife Science
Series AOct 3, 2007
Amount Raised: $8,953,320
Proacta

La Jolla, California, United States

Proacta is a clinical-stage biopharmaceutical company developing hypoxia-activated “prodrugs” for the treatment of cancer.

BiotechnologyHealth CareMedical Device
Series BFeb 7, 2007
Amount Raised: $35,000,000
Tolerx

Cambridge, Massachusetts, United States

Tolerx develops novel therapies that modulate T-cell activities to treat patients with autoimmune diseases, diabetes and cancer.

BiotechnologyHealth CareMedical
Series DOct 21, 2006
Amount Raised: $61,000,000
HistoRx

New Haven, Connecticut, United States

HistoRx is a biotech company developing personalized medicine to improve individualized patient care.

Alternative MedicineBiotechnologyPrecision MedicineTherapeutics
Series UnknownMay 17, 2006
Amount Raised: $2,000,000
GlobeImmune

Louisville, Colorado, United States

GlobeImmune focused on developing products for the treatment of cancer and infectious diseases based on our proprietary Tarmogen® platform.

BiotechnologyMedicalTherapeutics
Series BDec 16, 2005
Amount Raised: $34,300,000
Kereos

Saint Louis, Missouri, United States

Kereos is a biotechnology company developing molecular imaging agents and therapeutics to treat cancer and cardiovascular diseases.

BiotechnologyHealth CareLife ScienceTherapeutics
Series BSep 20, 2005
Amount Raised: $19,500,000
Tolerx

Cambridge, Massachusetts, United States

Tolerx develops novel therapies that modulate T-cell activities to treat patients with autoimmune diseases, diabetes and cancer.

BiotechnologyHealth CareMedical
Series DMar 29, 2005
Amount Raised: $31,000,000
Cellective Therapeutics

Gaithersburg, Maryland, United States

Cellective Therapeutics is a biopharmaceutical company that engages in B Cell research for cancer and autoimmune diseases.

BiotechnologyHealth CareTherapeutics
Series ASep 29, 2004
Amount Raised: $27,500,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator